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Generation of a Zn
2+
-free oxygenase of phenol hydroxylase from  
Pseudomonas sp. strain CF600 
Natalie Khor 
 The phenol hydroxylase enzyme from Pseudomonas sp. strain CF600 is involved in the 
conversion of phenol to catechol, which subsequent enzymes break down to precursors for the 
Krebs cycle. The protein is a multi-component enzyme that is composed of reductase (DmpP), 
oxygenase (DmpLNO dimer), activator (DmpM) and assembly (DmpK) subunits. The active site, 
found in DmpN of the oxygenase component, has a binuclear iron centre required for activity. In 
DmpN, previous experiments have shown that there is also a Zn
2+
 ion coordinated by four 
cysteine residues, but the role that it plays in the enzyme has yet to be elucidated.  
 Site-directed mutagenesis was previously performed on two of the cysteine ligands in 
DmpN (C433A and C437A) that form a complex with Zn
2+
, but attempts to express and purify 
the variant proteins were unsuccessful. In this thesis, different techniques were used to attempt 
removal of Zn
2+ 
from its binding site in the oxygenase.  These techniques included dialysis and 
column buffer exchange in the presence of a combination of chelating agents, 
ethylenediaminetetraacetic acid (EDTA) or tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN), 
reducing agents dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP) and a denaturant, 
urea. Protein samples were analysed with circular dichroism and fluorescence spectroscopy for 
secondary and tertiary structure changes, respectively. In addition, inductively-coupled plasma 
mass spectrometry (ICP-MS) was used to determine the metal content of the treated proteins. 
iv 
 
The most successful approach was the combination of TPEN, DTT and urea followed by dialysis 
against metal-free buffer, where Zn
2+ 
was reduced from 2.6 atoms per molecule in pre-dialysis to 
0.1 atoms per molecule after dialysis. This treatment, however, also resulted in the removal of 
Fe
2+
 from the enzyme. The method developed for the preparation of the apo-enzyme will enable 
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In the mid-eighteenth century, when the Industrial Revolution had just begun, many 
manufacturing plants were created and as a result chemical waste production increased. Phenol, 
an aromatic compound, along with its derivatives, is now produced in amounts of millions of 
kilograms per year from industrial sources such as oil refineries, pulp and paper, pesticide 
production, textiles and pharmaceutical
1
. Some phenolic waste finds its way into the 
environment.  As phenol is toxic to humans and other organisms, this can contribute to 
environmental pollution if it is not degraded or removed.  
Humans have very limited ability to completely degrade aromatic compounds. The three 
aromatic amino acids, phenylalanine, tyrosine and tryptophan, are some of the few that can be 
converted to Krebs cycle and glycolytic intermediates. When an aromatic xenobiotic such as 
phenol enters the human system, it is prepared for excretion in two steps: hydroxylation through 
cytochrome P-450 in the liver, and/or conjugation (glucuronidation or sulfation). The addition of 
polar groups renders phenol more water soluble so that it is more readily excreted.
2
 
Toxicity testing on animals such as mice and rabbits has been performed to determine the 
LD50 (lethal dose which is required to kill 50% of the population) of phenol. The Agency for 
Toxic Substances and Disease Registry (ATSDR) in the United States and Health Canada have 
complied information on studies from research papers reporting tests on animals that were 
administered phenol orally and dermally. The LD50 value for mice and rabbits given phenol 
orally ranged between 0.34 – 0.65 g/kg body weight3,4. Dermal exposure of rats to phenol gave a 





 Phenol in the Environment 
To remove pollutants such as phenol and its derivatives from chemical wastes or the 
environment, various physicochemical methods can be used: adsorption, oxidation, membrane 
separation and reverse osmosis.
7
 These methods, however, have limitations, are expensive when 
used to treat large amounts (for example, of soil or water), and in the process they can produce 
other toxic compounds.
8
 Incineration is another technique that is used when disposal of phenol is 
required.
9
 Electrochemical incineration of phenol and its derivatives is gaining popularity with 
the development of electrodes that are effective at decomposing these compound, producing 
carbon dioxide and water.
10
  
Bioremediation is an alternative method of environmental or waste clean-up. This 
involves using microorganisms to remove, from soil or water, phenolic compounds such as 
herbicides used in agriculture, or industrial waste, that are expelled into the environment.
11
 Over 
the course of time, bacteria and fungi growing in surroundings rich in aromatic compounds have 
acquired the ability to degrade chemicals such as phenol to carbon dioxide and water. They do so 
by using enzymes such as hydroxylases and diooxygenases to form catechol, which can be 
cleaved in the presence of oxygen, and further broken down to smaller molecules that these 
organisms use as sources of carbon and energy.  
The types of chemical groups, their positions (ortho, meta or para), and the number of 
substituents on the benzene ring govern the rate at which microorganisms breakdown an 
aromatic compound. These conjugated ring system compounds, such as phenol or benzoic acid, 
that are substituted with hydroxyl or carboxyl groups can be easily degraded by microbes, 
whereas halide, sulfonate or nitro groups positioned on a benzene ring create a bigger challenge 
3 
 
for microbial decomposition. For example, a study showed that regardless of position on the ring 
with respect to a hydroxyl or carboxyl group,  a halogenated compound was degraded in less 
than two weeks as opposed to one or two days without the halogen
12
. The position and number of 
chlorine substituents on the ring also affect the degradation rate: for example, o- and p-
chlorobenzoate are degraded faster than m-chlorobenzoate, and the more substituents there are, 
the less susceptibility to microbial degradation
13
there is. Longer aliphatic side chains on the 
benzene ring result in a slower rate of biodegradation compared to shorter chains, as shown by 
studies of aromatic herbicide degradation
14
. Cresols also require extra steps to be fully degraded 
by microorganisms. The methyl group on a cresol is either oxidized such that subsequent 
reactions allow it to be converted to catechol before it gets further degraded
15
, or the ring is 
oxidized to form a catechol with a methyl group that will eventually undergo meta-fission
16
. 
Phenol Degrading Bacteria and Their Metabolic Pathways 
 
There are two pathways by which bacteria catabolize phenol after it is converted to 
catechol by a monooxygenase, characterized by whether addition of oxygen to the ring results in 
meta- or ortho-cleavage.  In an ortho-cleavage pathway, catechol is cleaved by action of the 
enzyme catechol 1,2-dioxygenase, which inserts molecular oxygen into the ring between two 
hydroxyl substituents generating a non-aromatic dicarboxylic acid product (reviewed in  Ornston 
& Yeh 1982)
17
. Meta-cleavage of a catechol ring occurs between a hydroxyl group and an 
adjacent carbon that is not hydroxylated, generating a non-aromatic semialdehyde product 
(reviewed in Bayly & Barbour 1984).
17
 Figures 1.1 and 1.2, show the pathways subsequent to 
ring cleavage.   The final products of the meta-cleavage pathway for catechol are pyruvate and 
acetyl-CoA, both of which are fed into the tricarboxylic acid cycle (TCA cycle)
17
.  On the other 
4 
 






Figure 1.1 Meta-cleavage pathway for phenol degradation.  Permission to reprint and redraw obtained 




Figure 1.2 Ortho-cleavage pathway for phenol degradation. Permission to reprint and redraw obtained 
from publisher. (22) 
5 
 
The meta-cleavage pathway in the degradation of phenol is common in many 
pseudomonads including Pseudomonas sp. CF600, which is the subject of this thesis. Some 
species, such as Pseudomonas putida, can have both meta- and ortho-cleavage depending on the 
starting carbon source: benzoate is degraded via ortho ring cleavage whereas phenols and cresols 
are degraded via a meta-cleavage pathway
18
. Examples of non-pseudomonads that also have 
meta-cleavage pathways are Azotobacter vinelandii 206
19
 and Alcaligenes eutrophus
20
. 
Cleavage of catechol via the ortho-cleavage pathway leads to degradation of this 
aromatic compound but results in different precursors for the TCA cycle than the meta-cleavage 
pathway. A well-studied organism that uses the ortho ring fission pathway for phenol 
degradation via catechol is the yeast species, Trichosporon cutaneum. When grown on phenol as 
the sole carbon source, hydroxylation of phenol forms catechol, and catechol 1,2-oxygenase 
cleaves the bond between the hydroxyl groups to generate cis,cis-muconate
21
 (Fig. 1.2). Further 
studies confirmed that the β-ketoadipate pathway then follows and ultimately results in 
formation of succinate and acetyl-CoA as precursors for the Krebs cycle
22 , 23
 (Fig. 1.2). 
Purification and characterization of the phenol hydroxylase enzyme from T. cutaneum showed 
that it is a monomer of 148 kDa and contains FAD; it is not a multi-subunit protein
24
. Another 
yeast, Candida tropicalis, can degrade phenols, resorcinol and quinol using ortho ring fission but 
cannot decompose benzoates, cresols and other derivatives of phenol, unlike T. cutaneum
25
. 
 Bacterial species that use ortho-cleavage for aromatic degradation are also known, 
although the range of bacterial species is not as extensive as those using meta-cleavage
26
. One of 
the pioneering studies of the -ketoadipate pathway was using the bacterial species 





. Streptomyces setonii, another bacterial species, was the first strain of the 
Streptomyces genus reported to undertake phenol degradation using an ortho-cleavage pathway
31
.  
Pseudomonas sp. strain CF600 
 One of the bacteria most-studied in the degradation of phenols is Pseudomonas sp. strain 
CF600, which is capable of degrading phenol and methyl-substituted phenols using the meta-
cleavage pathway. The dmp operon of Pseudomonas sp. strain CF600 contains 15 genes 
dmpKLMNOPQBCDEFGHI that encode proteins involved in phenol hydroxylation and meta-
cleavage, as shown in Fig 2.
17 
The five genes, dmpLMNOP, downstream of the regulatory gene, 
dmpR, encode the multi-component enzyme phenol hydroxylase, which is involved in the 
hydroxylation of phenol to catechol. The five encoded subunits cluster into three components: a 
reductase (DmpP), an activator (DmpM) and oxygenase (DmpLNO).  
Reductase Component - DmpP 
DmpP is a 39 kDa protein
32
, containing an FAD prosthetic group and an iron-sulfur 
centre that plays a role in the delivery of electrons from NADH to the oxygenase.
33
 The FAD 
cofactor is the redox center of the DmpP protein and is responsible for accepting electrons from 








Figure 2. Schematic of dmp operon encoding 15 genes for phenol hydroxylase and meta-cleavage 
pathway enzymes from Pseudomonas sp. strain CF600. Obtained permission to reprint from publisher 
(17). 
 
Activator Component - DmpM 
DmpM is a small protein of 10 kDa
33 
containing no prosthetic groups and is required for 
a fully functional phenol hydroxylase enzyme.
35
 Single turnover experiments from the oxygenase 
of phenol hydroxylase observed lower product yield in the absence of DmpM compared to in the 
presence of this component, indicating that its role is to enhance the rate of product yield of the 
oxygenase component. Previous chemical cross-linking experiments using 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide (EDC) as a cross-linker have shown that DmpM interacts 
with DmpN and DmpLN of the oxygenase component, although the mechanism for how this 





Oxygenase Component - DmpLNO 
The oxygenase component of phenol hydroxylase (DmpLNO) forms a dimer of the three 
subunits. The molecular masses of DmpL, DmpN and DmpO are 34 kDa, 58 kDa and 13 kDa, 
respectively
33
.  The active site of the enzyme is found in the DmpN subunit and contains a diiron 
center thought to be responsible for oxygen activation: reduced DmpLNO in the presence of 
DmpM can turnover to produce catechol
34
. Without the presence of iron in the oxygenase, the 
enzyme is inactive.  Previous ICP-MS studies of recombinant enzyme in E. coli expressed 
without addition of iron have shown that iron content in oxygenase was 1.4 per monomer of 
DmpN and zinc content was also determined to be 0.7 per monomer
35
.  
Assembly Component - DmpK 
 Although the gene encoding DmpK, the assembly component with a molecular mass of 
12.5 kDa
33
, is contiguous with the set of genes that encodes phenol hydroxylase, it is not 
required for oxygenase activity.
36 
 Experiments using bis(sulfosuccinimidyl)suberate (BS
3
) as a 
cross-linker have shown that DmpK interacts with DmpL and DmpN of the oxygenase.
36
 At low 
concentrations of DmpK, it was shown to obstruct the interaction between DmpM and DmpLNO, 
and decrease turnover of substrate to products, as evident from activity assays
36
.  Interestingly, at 
low ferrous concentrations, DmpK appears to facilitate iron incorporation into the apo-enzyme 
and render the oxygenase functional
Error! Bookmark not defined.
. This observation suggested that the 
role of DmpK is to incorporate iron into apo-oxygenase when the concentration of iron is 
limiting, and hence DmpK may be considered to be an assembly component





Structure of Phenol Hydroxylase in Pseudomonas sp. OX1 
 The structure of phenol hydroxylase in Pseudomonas sp. strain CF600 has yet to be 
elucidated, but it has 79% DmpN, 62% DmpL and 54% DmpO sequence identity to the α-, β- 
and γ-subunits, respectively, of phenol hydroxylase from Pseudomonas sp. OX1.   The X-ray 
crystal structure of this hydroxylase, PHH (αβγ)2, in complex with its regulatory protein, PHM 
(corresponding to DmpM), has been determined
37
 (Fig. 3). As is evident from Fig. 3, PHM 
complexes with PHH just above the diiron centre. Since PHH is a dimer, there is one diiron 
centre in each α-subunit of the protein which is also the largest hydroxylase subunit, totalling 
four iron atoms. A zinc ion binding site is also present in each α-subunit. The zinc atom is 
coordinated by four cysteine residues (C399, C402, C432 and C436), as shown in Fig. 4. 
Sequence alignment of the CF600 and OX1 subunits (Fig. 5) have shown that the cysteine 
residues are conserved in the Zn
2+
 binding site, but the position of the cysteines are shifted one 
residue in DmpN.  The Zn
2+
 binding site is located at the C-terminal domain of the α-subunit of 















Figure 3. Quaternary structure of PHH and PHM from Pseudomonas sp. OX1 β-subunit of PHH 
(yellow), PHM (green), α-subunit of PHH (red), γ-subunit of PHH (cyan), iron atoms (dark blue spheres), 















-binding site on α-subunit of PHH of phenol hydroxylase from Pseudomonas sp. OX1. 
The zinc atom is coordinated by four cysteine residues (C399, C402, C432 and C436) at the C-terminal 













DmpN        YRYLTRDLAWETTYQKKEDVFPLEHFEGIKITDWDKWEDPFRLTMDTYWKYQAEKEKKLY  74 
α-subunit   YQYLTRDMAWEPTYQDKKDIFPEEDFEGIKITDWSQWEDPFRLTMDAYWKYQAEKEKKLY  73 
 
DmpN        AIFDAFAQNNGHQNISDARYVNALKLFLTAVSPLEYQAFQGFSRVGRQFSGAGARVACQM  134 
α-subunit   AIFDAFAQNNGHQNISDARYVNALKLFISGISPLEHAAFQGYSKVGRQFSGAGARVACQM  133 
 
DmpN        QAIDELRHVQTQVHAMSHYNKHFDGLHDFAHMYDRVWYLSVPKSYMDDARTAGPFEFLTA  194 
α-subunit   QAIDELRHSQTQQHAMSHYNKHFNGLHDGPHMHDRVWYLSVPKSFFDDARSAGPFEFLTA  193 
 
DmpN        VSFSFEYVLTNLLFVPFMSGAAYNGDMATVTFGFSAQSDEARHMTLGLEVIKFMLEQHED  254 
α-subunit   ISFSFEYVLTNLLFVPFMSGAAYNGDMATVTFGFSAQSDEARHMTLGLEVIKFILEQHED  253 
 
DmpN        NVPIIQRWIDKWFWRGYRLLTLIGMMMDYMLPNKVMSWSEAWGVYFEQAGGALFKDLERY  314 
α-subunit   NVPIVQRWIDKWFWRGFRLLSLVSMMMDYMLPNKVMSWSEAWEVYYEQNGGALFKDLERY  313 
 
DmpN        GIRPPKYVEQTTIGKEHITHQVWGALYQYSKATSFHTWIPGDEELNWLSEKYPDTFDKYY  374 
α-subunit   GIRPPKYQDVANDAKHHLSHQLWTTFYQYCQATNFHTWIPEKEEMDWMSEKYPDTFDKYY  373 
 
DmpN        RPRFEFWREQQAKGERFYNDTLPHLCQVCQLPVIFTEPDDPTKLSLRSLVHEGERYQFCS  434 
α-subunit   RPRYEYLAKEAAAGRRFYNNTLPQLCQVCQIPTIFTEKDAPTMLSHRQIEHEGERYHFCS  433 
 
DmpN        DGCCDIFKNEPVKYIQAWLPVHQIYQGNCEGGDVETVVQKYYHIKSGVDNLEYLGSPEHQ  494 
α-subunit   DGCCDIFKHEPEKYIQAWLPVHQIYQGNCEGGDLETVVQKYYHINIGEDNFDYVGSPDQK  493 
 
DmpN        RWLALKGQTPPTAAPADKSLGAA  517 
α-subunit   HWLSIKGRK-----PADKNQDAA  511 
 
 
Figure 5. Sequence alignment of Pseudomonas sp. CF600 DmpN and Pseudomonas sp. OX1 PHH α-
subunit. The Zn
2+
 binding site of both subunits is coordinated by four cysteine residues: C400, C402, 
C433 and C437 in DmpN and C399, C401, C432 and C436 in PHH α-subunit (shaded C indicates the 
cysteines involved in Zn
2+
 binding). The alignment was generated through NCBI Protein Blast program. 
Accession numbers: D37831 (DmpN) and 3U52_A (α-subunit). Similarity between the two sequences is 
79% identity. 
 
 Although the crystal structure of phenol hydroxylase in Pseudomonas sp. CF600 is not 
available, we were able to use the hydroxylase of OX1 strain to compare sequences and 
determine the possible Zn
2+
 binding domain and its coordination with the four cysteine residues. 
The role of the Zn
2+
 binding site has yet to be determined in both DmpN of CF600 and in the α-
subunit of OX1, though the hypothesis that it may be have a role in stabilization of the C-








 in Enzymes 
Zinc is the second-most abundant metal element found in nature, after iron, and it is 
required for biological functioning in living organisms. The earliest finding of a zinc-dependent 
metalloprotein was carbonic anhydrase, which is an enzyme that catalyzes the interconversion 
between carbon dioxide and bicarbonate
38
. It was discovered by Keilin and Mann in 1939.
39
 
Since this discovery, more than 300 other zinc-containing proteins from six classes of enzymes 
have been identified.
40
 Because zinc ions contain filled d-orbitals and are stable as Zn
2+
, they do 





 found in proteins has been shown to play catalytic and/or structural roles. 
Catalytic Roles of Zn
2+
 in Enzymes 
For a wide range of enzymes, catalytic Zn
2+
 is found at the active site and is involved in 




 can form 4, 5 and 6-coordinated complexes and have 
ligands that are labile, which are important properties for metals that behave as catalysts.
43
  In 
general, in enzyme active sites Zn
2+
 coordinates to three amino acid side chains that can be a 
combination of histidine (H), glutamate (E), aspartate (D) and cysteine (C), along with a solvent 
molecule that completes a tetrahedral coordination sphere
42
 (reviewed in 16). In a review 
article
44
 where 12 Zn
2+
-containing enzymes were surveyed, it was determined that histidine is the 
most common ligand found in the active site followed by glutamate, aspartate and cysteine.  
Catalytic Zn
2+
 in enzymes usually participates in the breaking and forming of bonds 
during conversion of substrate to product. In the case of carbonic anhydrase II, the active site 
Zn
2+
 is involved in activating a hydroxide ion for nucleophilic attack in the hydrolysis reaction
45
. 
The catalytic site can also be involved in stabilizing ligands with a carboxylate and polarization 
14 
 





 can also be involved in stabilization of charge in the transition state 
of a reaction
42
 (reviewed in 88).  





 can have structural instead of catalytic roles in proteins.  For example, Zn
2+
 
stabilizes the quaternary structure of aspartate transcarbamylase, which catalyzes the conversion 
of L-aspartate and carbamoyl phosphate to carbamoyl-L-aspartate
47
. As detailed in a review 
article
48
, zinc fingers are another example where Zn
2+
 plays a role in the stabilization of protein 
structures, most notably DNA binding domains. In general, Zn
2+
 ligands are commonly located 
in flexible loops instead of a rigid secondary structure, and these interactions stabilize not only 
the local but also, the overall structure of the enzyme
42
. Formation of tetrahedral geometry 
coordinated by four amino acid side chains for catalytic ions has been reported, with the 
difference being that the solvent is not a ligand. Also, in the formation of a tetradenate complex 
with Zn
2+
, cysteine side chains are the most common in structural Zn
2+
 centres because of the 
high affinity constants which stabilize the structure
49
. In the oxygenase component of phenol 
hydroxylase, Zn
2+
 is bound by four cysteine residues, which hints that it participates in 






 binds tightly to proteins that contain it, and in order to perform studies on the 
binding site chelators are often used to first remove the metal ion.  Many chelators have been 
shown capable of sequestering Zn
2+
, including N,N,N,N-tetrakis (2-pyridylmethyl) 











 M, for TPEN and EDTA, 
respectively. These chelators are not only specific to Zn
2+
, but can also be used for extraction of 
other metals, such as Fe
2+




 M for TPEN and 10
-14.3
 M for 
EDTA. Both chelating agents form hexadentate complexes, where TPEN sequesters metal ions 
through its six nitrogen atoms, and EDTA does so with the two nitrogen atoms and four 
carboxylic acid groups. 
 
Figure 6. Structure of metal chelators used in this study. N,N,N,N-tetrakis (2-pyridylmethyl) 
ethylenediamine (TPEN) and ethylenediaminetetraacetic acid (EDTA). 
 
YHS Domain 
 Pfam is a database with a collection of protein families that have been manually curated 
to catalogue the presence of domains and their functions in different proteins.
51,52
  Amino acid 
sequence alignments allow us to identify these conserved domain regions in proteins and may 
suggest roles that these domains play.
53
  
The YHS domain, as its name implies, is a short region of approximately 50 amino acids 
that has conserved tyrosine (Y), histidine (H) and serine (S) residues
52
. YHS domains that are 
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present in ATPases, such as those involved in copper transport, are thought to participate in 





It is interesting to note that a YHS domain is found in the larger 
subunit of oxygenases in multicomponent phenol hydroxylases that are also associated with 
DmpK-like proteins
54
. In Pseudomonas sp. strain CF600, the Zn
2+
 binding site is found in the 
YHS region.  As discussed above, DmpK is believed to be involved in facilitating association of 
apo-oxygenase with iron, and it has been shown to physically associate with the large oxygenase 
subunit.  Together, these observations suggest that the YHS domain may play a role in the 
interaction between DmpK and the oxygenase, as well as assembling iron into the 
apooxygenase
Error! Bookmark not defined.
. 
Specific Objectives 
Although extensive studies on the iron binding site of phenol hydroxylase in 
Pseudomonas sp. strain CF600 have been carried out
33,34
 , the Zn
2+
 binding site located in the 
large subunit of the oxygenase in this and other phenol hydroxylases has been minimally studied. 
The goal of this project was to study the role of Zn
2+
 in phenol hydroxylase structure and 
function.  As is evident from the review presented above, by comparison with Zn
2+
 binding sites 
in other proteins, the tetradentate cysteine ligation suggests that a structural role is most likely for 
the Zn
2+
 in phenol hydroxylase.   
Initially, the role of Zn
2+
 was experimentally approached by substituting one of the 
conserved cysteine ligands for Zn
2+
 in the oxygenase protein from Pseudomonas sp. strain 
CF600.  It proved impossible to produce any variant oxygenase in soluble form, so the second 
approach was to devise a method to successfully remove Zn
2+
 from its binding site using 
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chelators, reducing agents and denaturants. Once the metal ion has been removed, it would 






MATERIALS AND METHODS 
Materials 
 
The LMW Calibration Kit Amersham
TM
 For SDS Electrophoresis was from GE Healthcare (Baie 
d’Urfé, QC) and albumin standards for BCA assays were obtained from Fisher Scientific 
(Ottawa, ON).  TPEN, NADH, ampicillin and carbenicillin were purchased from Sigma 
(Oakville, ON); EDTA, DTT and IPTG were from BioShop (Burlington, ON). DNaseI was 
purchased from Roche (Laval, QC) and Chelex
®
100 resins were obtained from BioRad 
(Mississauga, ON). Reagent A and Reagent B for Pierce BCA Protein assays were from Thermo 
Scientific (Ottawa, ON). 
SDS-PAGE  
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to estimate 
the molecular weights of proteins, to estimate the purity of protein preparations, and to confirm 
the presence of a protein of interest. All protein samples were separated using a 12% acrylamide 
separating gel and 3.9% acrylamide stacking gel, as previously described
55
, with some 
modifications. Briefly, samples were mixed with an equal volume of 2-fold concentrated 
reducing sample buffer, containing SDS, β-mercaptoethanol and bromophenol blue. 
Electrophoresis was conducted at 200V for 40 min using a BioRad minigel apparatus. A 
Coomassie staining solution (0.1% Coomassie Blue R-250, 40% methanol and 10% acetic acid) 
and destaining solution (10% methanol, 10% acetic acid and 2% glycerol) were used to enable 
the visualization of the protein bands on the gel. The molecular weight standards consisted of 
phosphorylase b (97 kDa), albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa), 
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trypsin inhibitor (20.1 kDa) and α-lactalbumin (14.4 kDa) and were purchased as a mixture from 
GE Healthcare. 
Protein Concentration Estimation 
 
All phenol hydroxylase oxygenase (monomer) component (native and treated) concentrations 
were estimated using trichloroacetic acid (TCA) precipitation to remove interfering compounds, 
followed by the bicinchoninic acid (BCA) assay, essentially as described.
55
 Briefly, samples 
were first incubated with 0.15% (w/v) sodium deoxycholate for 15 min at room temperature and 
then centrifuged at 16,060 x g with 3.2% (w/v) trichloroacetic acid for another 15 min before re-
dissolving the pellet with 5% (w/v) SDS in 0.1% NaOH (25 L). Triplicates of each sample were 
prepared. Albumin standards were used and prepared at concentrations of: 0 mg/mL, 0.025 
mg/mL, 0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.75 mg/mL, 1 mg/mL and 1.5 mg/mL before 
mixing with the working reagents. These concentrations of standards were used to generate the 
standard curve. The working reagents were prepared by mixing a 50:1 ratio of Reagent A: 
Reagent B. The assay mixture was incubated at 60 
o
C for 30 min on a heating block and allowed 
to cool on ice for 5 min before reading the absorbance at 562 nm with the Bio-TekPowerWave 
HT microplate reader.  
Bacterial Growth and DmpLNO Expression 
 
The expression of the DmpLNO oxygenase component of phenol hydroxylase was performed by 
transforming pPOW100 (dmpK inserted into the plasmid), as previously described.
56
 Mutant 
plasmids of variant oxygenase encoding cysteine (C) to alanine (A) substitutions (C433A and 
C437A) were generated as previously described
57





C (following wild-type protein procedure) or at 18 
o
C for 16 h or 48 h. The cells 
were grown in Luria Broth (LB) medium with 100 μg/mL ampicillin or carbenicillin antibiotic. 
After OD600 reached between 0.8-1.0, a final concentration of 0.5 mM IPTG was added to 
cultures for induction at 37 
o
C for 3 h. Cells were collected by centrifugation at 14,295 x g with a 
JA-10 rotor, and cell paste was stored at -80 
o
C until further use.  
Crude Extract Preparation for Purification of DmpLNO 
 
The cell paste (20-25 g) was resuspended in a buffer of 50 mM Tris-HCl (pH 8.0) and 10% 
glycerol (2 mL buffer/gram of cell paste), and a few milligrams of DNaseI were added, as 
previously described.
58
  Sonication of cells was performed at 10 bursts of 15 s on ice and a final 
concentration of 200 μM ferrous ammonium sulfate was then added from a stock solution in 10 
mM HCl. Cell debris was removed using the Beckman Coulter Optima L-100 ultracentrifuge 
with Ti45 rotor at 104,350 x g for 1 h at 4 
o
C. The supernatant was used for the purification of 
DmpLNO as described below. 
Purification of Phenol Hydroxylase DmpLNO 
 
The purification of the oxygenase component, DmpLNO, was performed as previously described, 
at 4 
o
C with minor modifications.  A brief description is given below.   
Fast-Flow DEAE-Sepharose Column (2.6 x 22.7 cm).  The anion-exchange column was washed 
with distilled water and equilibrated with 50 mM Tris-HCl (pH 8.0) containing 10% glycerol 
(“TG buffer”) before loading the crude extract. Unbound proteins were eluted with 75 mM NaCl 
in TG buffer. A gradient of 75-275 mM NaCl in TG buffer was applied at a flow rate of 6 
mL/min to elute the oxygenase component. The OD280 of the fractions was measured to estimate 
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protein concentration, while the detection of DmpLNO protein in the fractions was performed by 
SDS-PAGE, using a previously-purified DmpLNO sample for comparison. Fractions containing 
the oxygenase were pooled and brought to 65 % saturation with ammonium sulfate (40.4g 
(NH4)2SO4 in 100 mL solution), and incubated at 4 
o
C for 30 min before collecting the precipitate 
after centrifugation at 15,303 x g for 30 min. The pellet was dissolved in a minimum volume of 
30 mL TG buffer, and the solution was centrifuged at 3,826 x g for 20 min, and the supernatant 
was then loaded onto the next column. The Fast-Flow DEAE Sepharose column was washed and 
stored in 2 M NaCl. 
Phenyl Sepharose High Performance Column (2.6 x 13.5 cm).  The hydrophobic interaction 
column was washed with distilled water and equilibrated with TG buffer containing 0.15 M 
NaCl. Once the concentrated sample (30 mL) from the previous step was loaded, the same 
equilibration buffer was used for elution until the fractions were no longer visibly yellow in 
colour. TG buffer was then applied and the column was washed until the OD280 of the eluate 
dropped below 0.2 before eluting DmpLNO with 5 mM Tris-HCl (pH 8.0), containing 10% 
glycerol at a flow rate of 2 mL/min. The fractions with the highest OD280 absorbance values and 
eluted with DmpLNO (as judged SDS-PAGE analysis) were pooled together. The pooled 
fractions were brought to a 50 mM buffer concentration with 1 M Tris (pH 8.0), before 
concentrating to 5 mL using ultrafiltration with an Amicon YM30 membrane. The column was 
washed and stored in 50% ethylene glycol. 
Sephacryl S-300HR Gel Filtration (2.6 x 77.2 cm).  This size-exclusion column was equilibrated 
with TG buffer before loading the concentrated sample from the Phenyl Sepharose purification 
step. The oxygenase was eluted with the same buffer at a flow rate of 1 mL/min. Fractions 
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showing the higher OD280 values and the highest purity of DmpLNO (as judged by SDS-PAGE 
analysis) were pooled and concentrated by ultrafiltration with an Amicon YM30 membrane. The 
column was washed and stored in 0.03% sodium azide in TG buffer. 
Phenol Hydroxylase Activity Assay 
 
The assay was performed at 25 
o
C in 1 mL of 50 mM Tris acetate (pH 7.5) buffer containing 345 
μM NADH, 0.78 μM DmpP, 0.24 μM DmpM, 0.65 μM DmpLNO and catechol 2,3-dioxygenase 
as previously described
36
. A final concentration of 1.23 mM phenol was added, initiating the two 
step reaction converting phenol to catechol and from catechol to the yellow-coloured product, 2-










All glassware, microfuge tubes and pipette tips for this procedure were treated with 7-10% 
HNO3 for at least 1 h and rinsed with ultrapure water before use, or allowed to dry in a 37 
o
C 
incubator overnight.  
Dialysis Method. Native oxygenase (9 – 11 μM) was incubated with different combinations of 
DTT (2 mM), EDTA (5 mM), TCEP (2 mM), TPEN (5 mM), and urea (0.5 M ) at room 
temperature or 4 
o
C over a period of at least 16 h. SpectraPor
®
 Membrane with a MWCO 6-8K 
from Spectrum Laboratories Inc. (Rancho Dominguez, CA) was used for dialysis to remove 
metals, chelating, denaturing and/or reducing agents. The membrane was originally stored in 
EDTA (1 mM) and 25% ethanol solution and soaked in Chelex-treated TG buffer before use. 
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Samples were first dialysed against Chelex
® 
100-treated TG buffer at 4 
o
C. The buffer was 
changed a total of three times over a period of three days for all the samples.  
NAP-5 Column Method. Samples were passed through a NAP-5 column for buffer exchange. 
The column was equilibrated with three bed-volumes of metal-free TG buffer. A volume of 0.4 
mL sample was applied to the column followed by 0.1 mL metal-free TG buffer. Collection of 
the sample in a metal-free tube was done following the addition of 0.85 mL metal-free buffer. 
Mini Chelex
® 
Column Treatment. The proteins were first passed through the NAP-5 column (as 
above). The eluted sample was then transferred to a mini-Chelex
®
 column (5 cm) and the eluate 
was collected. 





Native or apo-oxygenase proteins (2.2 – 4.5 μM) in a final volume of 200 μL were digested in 10% 
HNO3 at 50 
o
C until the precipitate was solubilized (which could take up to a period of 5 days 
and a loss of 10-20 μL of sample had occurred). Digested proteins were diluted 10-fold in 
ultrapure water and submitted for LC-ICP-MS (Agilent 7500ce) analysis, along with a sample of 
ultrapure water, Chelex
®
100-treated TG buffer and the last dialysis buffers of each sample.  





metals at concentrations of 1, 5, 10, 50 and 100 ppb (slight concentration changes 
may be applied for different sample preparations, but these values were mostly used). Internal 











Sample Preparation. A concentration of ~1 μM DmpLNO protein was used for CD and 
fluorometric analyses.  
Circular Dichroism.  Secondary structure changes and protein stability were analysed using far-
UV CD spectroscopy. All CD spectra of samples were scanned at 25 
o
C using a Jasco-815 CD 
spectrometer. The spectra were collected over an average of 5 scans between the region of 200-
260 nm using a 0.2 cm path length cell (containing ~400 μL of sample) with a scan rate of 20 
nm/min and response time of 1 sec. The reported spectra resulted from a 0.2 nm data pitch, 1 nm 
bandwidth and sensitivity of 100 mdeg.  
For thermal denaturation analysis, Jasco Pelletier temperature control was used with the same 
cell path length as above, and spectral changes were monitored at a wavelength of 222 nm, from 
25 to 95 
o
C with a temperature slope of 25 
o
C/h and response time of 0.25 sec. A 0.2 
o
C data 
pitch, 2 s delay time, 1 nm bandwidth and 100 mdeg sensitivity were used to generate the spectra.  
Fluorescence Spectroscopy. Tertiary structure changes and stability were probed using 
fluorescence spectroscopy. Fluorescence emission spectra were collected at 25 
o
C or between 25 
and 80
o
C or 95 
o
C at intervals of 5 
o
C using a Varian Cary Eclipse Fluorescence 
Spectrophotometer. Samples (~600 μL) were loaded into a 5 mm self-masking quartz cuvette 
(two sides with clear windows). The spectra were obtained between 300 and 400 nm, with 
excitation at 280 nm and slit widths of 5 nm. The voltage was set at MED with a fast scan speed 
collecting spectra over an average of 10 scans.  
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A Single Cell Pelletier temperature control unit was used in thermal denaturation analysis of the 
native protein between 25 and 95 
o
C at 5 
o
C intervals. Manual temperature control was used for 
denaturation of treated protein samples between 25 to 80 
o
C, at 5 
o
C intervals. The settings of the 
fluorometer were the same as above. The samples were equilibrated for 30 s after the 
temperature stabilized before taking a scan. 
Generation of Fluorescence Intensity and Wavelength Graphs 
 
The highest intensities at each temperature point were determined from the raw data of the 
fluorescence emission spectrum.  The wavelength maximum that was estimated corresponds to 
the highest fluorescence intensity unit at the specific temperature. 
Estimation of Tm values 
 
Tm values were estimated by taking the average of the temperatures of the point where the curve 
begins to increase at the bottom of the sigmoidal curve and the point where it starts to level off at 











Wild-Type Oxygenase Purification from Pseudomonas sp. CF600 
 
 Purification of the wild-type oxygenase following the procedures outlined in Materials 
and Methods showed that the three subunits of the enzyme co-purify in all purification steps, as 
expected from previous results
35
. The total amount of protein obtained from 25 g of cell paste 
was 72 mg (10.3 mg/mL), with a specific activity of 370 nmol/min/mg.  
Variant Oxygenase Protein C433A & C437A Expression at 18 
o




 Plasmids encoding phenol hydroxylase variants C433A and C437A were constructed by 
a former M.Sc. student, Amy Wong and retested for expression
57
. Cell growth and expression of 
the protein in E. coli was performed as described in Materials and Methods. Inclusion bodies 
were obtained after growth either at 37 
o
C for 3 h or 18 
o
C for 16 h, (data not shown), which was 
also as observed previously
57
. 
Variant Oxygenase Protein C436A Expressed at 18 
o




 The possibility that soluble protein yield could be improved by the addition of Zn
2+
 to the 
culture medium was tested using variant oxygenase C436A.  The hypothesis is that the variant 
protein is destabilized by the loss of Zn
2+
, and higher concentrations of Zn
2+
 might allow the 
metal to bind and stabilize the structure.  Bacterial growth conditions were the same as for native 
protein (Materials and Methods), but induction with IPTG was at 18
o
C for a period of 48 h rather 
than 16 h. A control uninduced sample was also prepared to compare with the results of 




Figure 7. SDS-PAGE (12%) gel electrophoresis of C436A variant protein expressed at 18 
o
C for 48 
h under inducing (with IPTG) and non-inducing conditions.   Lane 1: low molecular marker; Lane 2: 
purified wild-type oxygenase; Lane 3: uninduced pellet; Lane 4: uninduced pellet after addition of Zn
2+
; 
Lane 5: uninduced supernatant after addition of Zn
2+
; Lane 6: induced pellet; Lane 7: induced pellet after 
addition of Zn
2+
; Lane 8: induced supernatant after addition of Zn
2+
. All samples were diluted 1:1 with 2-
fold sample buffer. 15 μL of samples were loaded onto gel except the low molecular weight marker with 
a volume of 5 μL. 
 
 After expression under inducing or non-inducing conditions at 18 
o
C for 48 h, the cell 
paste was resuspended in TG buffer (~1 g/mL),  sonicated, and then centrifuged at 16,060 x g. 
The pellet was then resuspended in sample buffer and loaded onto the gel (Fig. 7 lanes 3 & 6). 
Increased DmpN expression was observed under inducing conditions as opposed to uninduced, 
although it was difficult to visualize if there was expression for DmpL and DmpO. These 
sonicated pellets were then resuspended in buffer containing added ZnCl2 (2 mM) in an attempt 
to solubilize the protein, and then centrifuged to collect the supernatant, but most of the protein 
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still remained as inclusion bodies as there is very little protein found in the supernatant (lanes 5 
& 8). 
 It is possible that the substitution of alanine for cysteine destabilizes the structure more 
than a cysteine to serine substitution.  For that reason, expression of cysteine to serine variants in 
E. coli has also been attempted in our lab for each of the four cysteine residues (C400, C403, 
C433 and C437) that coordinate Zn
2+
 in the oxygenase. These proteins were expressed at 37 
o
C 
for about 3 h, or at 18 
o
C for at least 12 h, but under all conditions there was little expression of 
DmpN, DmpL and DmpO, and/or they were insoluble. (Dr. Elisabeth Cadieux, personal 
communication). 




 The difficulty in obtaining soluble protein after substituting the cysteine residues with 
alanine or serine residues prompted an alternative approach involving attempted removal of Zn
2+
 
from the native enzyme. Considering the effects on the oxygenase structure of substituting any of 
the Zn
2+
 binding ligands, leading these variants to be found in inclusion bodies, it was 
anticipated that probes of structure such as fluorescence or circular dichroism spectroscopies 
might be useful in detecting changes at the Zn
2+
 binding site. 
Chemical reagents such as chelators having high affinity for Zn
2+
, reducing agents that 
could help prevent the formation of disulfide bonds between the four cysteine ligands, and 
denaturants to unfold the protein and aid in easier accessibility to chelators and reductants, were 
used in different combinations to attempt Zn
2+
 removal. Once Zn
2+
 has been removed, the effects 
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on enzyme structure and function can be examined by studying the apoenzyme and reconstituted 
holozyme. 
Structure Stability of the Native Oxygenase Probed Using Circular Dichroism and 
Fluorescence Spectroscopies  
 
 Before attempting to remove Zn
2+
, the native structure of the protein was first probed 
spectroscopically to set a baseline for comparison for metal ion removal experiments. Secondary 
and tertiary structures of the native oxygenase were examined using far–UV circular dichroism 
(CD) and fluorescence spectroscopies, respectively.  
CD spectroscopy was used to probe the temperature stability of the native enzyme (Fig. 
8).  Fig. 8A shows the CD spectra of the native protein at 25 
o
C and 95 
o
C, and Fig. 8B is the 
thermal denaturation curve of the protein, as monitored by CD spectroscopy. Scans collected at 
25 
o
C and 95 
o
C were corrected with the blank (TG buffer).  
A   B  
Figure 8. Circular dichroism studies of native oxygenase. A. Spectra at 25 
o
C and 95 
o
C. B. Thermal 
denaturation scan (25 to 95 
o
C) of native protein at a rate of 25 
o
C/h and wavelength of 222 nm. Final 
concentration of protein is 0.90 μM. 
 
 The spectrum of the native protein at room temperature exhibits a double minimum at 











































indicating protein unfolding and/or precipitation. As shown in Fig. 8B, with increasing 
temperature the ellipticity starts to decrease at around 45 
o
C and continues to decrease until 65 
o
C.  
An additional small change in signal then occurs from 65 to 95 
o
C. Insoluble protein was 
detected in the cuvette when it was removed from the CD spectrometer indicating irreversible 
denaturation. Intrinsic fluorescence was used to monitor the effects of temperature on the tertiary 
structure of the native protein. Fig. 9A shows the intrinsic fluorescence emission spectra of 








A   
B  C   
 
Figure 9. Intrinsic fluorescence spectra of native oxygenase as a function of temperature. A. 
Fluorescence spectra at temperatures from 25 to 95 
o
C. B. Change in fluorescence intensity with 
temperature. C. Red-shift of emission wavelength maximum with increasing temperature. Excitation 
wavelength in all experiments was 280 nm. Concentration of sample was 0.90 μM. 
 
 The temperature range where the largest change in emission intensity takes place is from 
45 to 60 
o






























































































8B).  A spectral red-shift occurred as the temperature increased, consistent with the exposure of 
buried aromatic amino acids (tyrosine and tryptophan) to a more polar environment as the 
protein unfolded. The red-shift appeared to cease when the sample reached 60 
o
C, the same 
temperature at which ellipticity change ceased (Fig. 8B). The decrease in fluorescence intensity 
that accompanies the red shift was also observed with the increase in temperature, which results 
in the lowering of the quantum yield as a consequence of the tryptophan residues
60
 being 
exposed to the polar solvent
61
 as well as the higher temperature. 
Metal Content in Native Oxygenase 
 
 To examine the metal content of the native oxygenase protein, ICP-MS was used. Seven 
different samples were prepared for ICP-MS analysis using three different preparations of 
purified oxygenase. Samples were digested with 10% HNO3 and diluted 11-fold with ultrapure 
water for analysis, as described in “Materials and Methods”. Table 1 below shows the results of 



















































1 4.6 2.9 
2 3.4 3.1 
3 3.4 2.3 
4 3.9 3.0 
5 4.3 3.1 
6 4.5 3.1 
7 N/A  2.0 
Standard Deviation 0.5 0.5 
Average 4.0 2.5 
 
Table 1. ICP-MS metal analysis of iron and zinc in native oxygenase protein. The average of iron and 
zinc content was calculated using the results of the 7 sample preparations. Final concentration of samples 
varied between 0.45 to 5 μM. N/A represents not applicable data. 
 
Iron content was measured on each of six different preparations (average of triplicate or 
quadruplicate data of each preparation) of oxygenase, whereas zinc content was measured seven 
times, and the final average of all measurements was taken. Previously, the iron and zinc content 
using ICP-MS of native DmpLNO expressed with DmpK purified from E. coli (without addition 
of ferrous ammonium sulphate during isolation) showed that each monomer of oxygenase had 
1.4 Fe and 0.7 Zn, which corresponds to 2.8 Fe and 1.4 Zn in the dimers
35
. The iron content 
obtained from the expression of DmpLNO in the presence of DmpK (with ferrous ammonium 
sulphate) in Pseudomonas sp. CF600 were between 2.4 to 3.6 mol Fe
2+
 per mol of oxygenase
34
. 
In the phenol hydroxylase oxygenase component of Pseudomonas sp. OX1, an orthologous 
protein of Pseudomonas sp. CF600 oxygenase, iron and zinc content were four and two mol per 
34 
 
mol of oxygenase, respectively
Error! Bookmark not defined.
. We obtained 4.0 ± 0.5 Fe
2+
/ mol oxygenase 
and 2.5 ± 0.5 Zn
2+
/ mol oxygenase, which agree quite well with the values obtained previously.  
Overview of the Zn
2+
-Chelating Experiments  
 
In order to remove Zn
2+ 
from the enzyme, treatments with various combinations of 
chelators (EDTA, TPEN), reductants (DTT, TCEP) and mild denaturants (low concentrations of 
urea) in conjunction with dialysis were attempted. Another method that was used was 
chromatography on Chelex, a metal ion-binding resin.    




 at the binding site is believed to be coordinated by four cysteine residues (C400, 
C403, C433 and C437) through thiol-Zn
2+
 bonds. It is thus possible that the presence of the 
reductant could stimulate the removal of Zn
2+
. Its presence may also help keep the cysteine 
residues reduced if Zn
2+ 
is removed through dialysis. Thus, incubation of the oxygenase with 
DTT (2 mM) over a period of 16 h at room temperature was followed by dialysis of samples 
against Chelexed-TG buffer lacking DTT, with two buffer changes over a two day period, at 4 
o
C. 
Samples were then digested with 10% HNO3 and diluted 11-fold before ICP-MS analysis. Table 




















* This value was the average of 4 values with a 
standard error of 0.3 
 
Table 2. ICP-MS analysis of iron and zinc in DTT-treated oxygenase before and after dialysis.  
Final concentrations of the samples were 2.7 μM.  
 
Iron and zinc contents were examined and compared to untreated protein (Table 1) to 
determine whether either of the metals was removed during treatment with DTT/dialysis. As is 
shown in Table 2, iron and zinc contents were essentially the same before and after dialysis. This 
indicates that DTT alone was not sufficient to facilitate Zn
2+
 release from the enzyme. 
Spectroscopic Analysis of Oxygenase Treated with EDTA and DTT 
 
To assist in extraction of Zn
2+
 from the enzyme, an effective chelator, 
ethylenediaminetetraacetic acid (EDTA), was introduced into the sample in addition to the 
reducing agent, DTT
62
. Oxygenase was incubated with either EDTA (5 mM) alone, or EDTA (5 
mM) and DTT (2 mM), overnight at room temperature, followed by dialysis the next day at 4 
o
C 
against metal-free buffer containing EDTA only, or EDTA/DTT. This was followed by two 
rounds of dialysis against metal-free buffer without EDTA or DTT. 
The far-UV CD spectra of the EDTA/DTT-treated proteins before dialysis (Fig. 10A) 
show that at 95 
o
C, the α-helical structure is lost as compared to the 25 oC scan: this behaviour is 
essentially the same as for native oxygenase (Fig. 8). However, when the oxygenase was treated 
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with EDTA and DTT, then dialyzed, the CD spectrum at 95 
o
C indicates that the α-helical 
structure is not completely lost (Fig. 10B). The thermal denaturation curves of the four EDTA or 
EDTA/DTT-treated samples confirm that complete denaturation is achieved with samples before 
dialysis, but after dialysis, the samples do not completely denature (Fig. 10C). 
The transition midpoint temperatures, Tm, (determined by taking the average temperature 
between the lowest and highest CD signal) of the denaturation curves for pre-dialysis EDTA and 
EDTA/DTT treated samples were 57 
o
C, which is similar to Tm for the native protein of 54 
o
C.  





C and 50 
o
C, respectively). Thus, in addition to incomplete denaturation after EDTA 










A      B  
C   
Figure 10. Far-UV CD spectra of EDTA and EDTA/DTT treated samples pre- and post-dialysis. A. 
EDTA and DTT-treated oxygenase (before dialysis) scans at 25 
o
C and 95 
o
C. B. EDTA and DTT-treated 
oxygenase (after dialysis) scans at 25 
o
C and 95 
o
C. C. Thermal denaturation curves of native oxygenase 
(control) and treated oxygenase pre- and post-dialysis at a wavelength of 222 nm with a scan rate of 20 
nm/min. Final protein concentrations were 0.90 μM. Note: Spectra after treatment of oxygenase with 
EDTA alone are not shown, but they have the same spectra as samples treated with EDTA/DTT. 
 
 Temperature denaturation of these samples was also monitored by fluorescence 
spectroscopy (Fig. 11).  In these experiments, it was only possible to monitor changes up to 80 
o
C, which is the limit of the thermostatted water bath. For each sample, the wavelength 
maximum at 25 
o
C was between 335 to 338 nm, and the wavelength maximum shifted in a 
similar fashion as the temperature increased to 80 
o










































































dialysed samples shifted to somewhat higher wavelengths compared to those samples that were 
not dialyzed (Fig. 11B). The fluorescence signal intensity decreased with increasing temperature 
in a similar fashion for all samples (Fig. 11A).  
A   
B   
Figure 11. Intrinsic fluorescence of EDTA and EDTA/DTT-treated oxygenase pre- and post-dialysis 
as a function of temperature. A. Fluorescence intensity changes with increasing temperature. B. Peak 
emission wavelength changes with increasing temperature. Excitation wavelengths in all experiments 
were performed at 280 nm. Scans were collected at every 5 
o
C from 25 to 80 
o
C.  The samples were from 





























































Metal Analysis of EDTA-Treated Samples 
 
 Iron and zinc contents for dialysed and incubated samples (from the same stock used 
previously for CD and fluorescence analysis) are shown in Table 3. These data indicate that the 
EDTA or EDTA/DTT treatments, with or without dialysis, were unable to eliminate iron or zinc 
from the oxygenase despite the fact that the stability of the protein is affected by the different 




Mol metal ions 

































             *These values were the average of two values that differed at most by 10% 
Table 3. ICP-MS metal analysis of iron and zinc in oxygenase protein samples. Final concentrations 
of samples were 2.2 to 2.7 μM.  
 
Spectroscopic Analysis of TCEP-Treated Oxygenase in the Presence and Absence of EDTA 
 A reducing agent that is more stable and more effective than DTT in preventing 
formation of disulfide bonds is Tris(2-carboxyethyl)phosphine (TCEP)
63
. This reductant was 
tested as an alternative to DTT: samples were incubated with EDTA (5 mM) and TCEP (2 mM) 
overnight (~ 16 h) and then dialysed against Chelex
®
-treated TG buffer that contained EDTA 
and TCEP in the first round of dialysis overnight at 4
 o
C. The next two changes of buffer did not 
include the chelator and reducing agent. Fig. 12 shows the CD spectra at 25 
o
C and 95 
o
C as well 
40 
 
as the thermal denaturation curves for the two oxygenase samples that were incubated overnight 
with TCEP or TCEP/EDTA, pre- and post-dialysis. . 
 The Tm values for TCEP and TCEP/EDTA treated oxygenase (prior to dialysis) were 
approximately 56 
o
C, which is essentially the same as for the EDTA and EDTA/DTT treated 
samples (Fig. 10A & B). After dialysing the two treated samples, Tm values dropped to 50 
o
C for 
TCEP-treated oxygenase and 51 
o
C for the TCEP/EDTA-treated sample, consistent with those 
observed after EDTA/DTT treatment.  
Figs. 12A & B show the spectra at 25 
o
C and 95 
o
C of samples of post-dialysis 
TCEP/EDTA-treated and TCEP-treated oxygenase, respectively. At 25 
o
C, both spectra show the 
α-helical character of the protein, but after denaturation at 95 oC, the α-helicity is lost. This can 
be better observed in the CD thermal denaturation scan (Fig. 12C) where both pre-dialysis TCEP 
and TCEP/EDTA treated samples denature completely after 65 
o
C, as indicated by the decrease 
in ellipticity to almost 0 mdeg. The CD signal for dialysed proteins, however, starts to level off at 
-35 mdeg at 55 
o





A    B   
 
C   
 
Figure 12. CD spectra and thermal denaturation curves of pre- and post-dialysis TCEP and 
TCEP/EDTA-treated oxygenase samples. A. CD spectra of TCEP (2 mM) and EDTA (5 mM)-treated 
oxygenase, after dialysis, at 25 
o
C and 95 
o
C. B. CD spectra of TCEP (2 mM)-treated oxygenase after 
dialysis at 25 
o
C and 95 
o
C. C. CD thermal denaturation curves of TCEP-treated oxygenase in the 
presence or absence of EDTA. Scans were performed at room temperature, and thermal denaturation 
scans were taken between 25 to 95 
o
C at a rate of 25 
o
C/h. Final concentration of protein was 0.90 μM. 
 
 Thermal denaturation of these samples was also examined using fluorescence 
spectroscopy as a probe.  The decrease in fluorescence intensity (Fig. 13A) and shift in 












































































fluorescence intensity commences immediately after 40 
o
C and continues to drop steadily until 
the end of the temperature scan at 95 
o
C.  The shift in emission maximum wavelength starts at 40 
o
C and appears to stabilize when the temperature reaches 65 to 70 
o
C. None of the dialysed 
samples heated to 95 
o
C showed visible precipitates as compared to the samples before dialysis, 
where protein precipitate was observed after heating. 
The change in wavelength of the maximal signal in the fluorescence spectra of all four 
samples seems to have stabilized at 55 
o
C (Fig. 13B), which is similar to the Tm values (51 to 56 
o
C) of the treated samples determined from the denaturation spectra (Fig. 12C), but the 
fluorescence intensity of the samples still continues to decrease with increasing temperature (Fig. 







A   
B   
Figure 13. Intrinsic fluorescence intensity of TCEP- and TCEP/EDTA treated oxygenase samples 
pre- and post-dialysis. A. Fluorescence intensity change with increasing temperature. B. Emission 
wavelength maximum changes with increasing temperature. Excitation wavelength for all samples was at 
280 nm. Spectra were collected at every 5 
o
C from 25 to 95 
o
C. The values in the graphs were generated 



































































Metal Content in Oxygenase after TCEP Treatment 
 
The results from the temperature denaturation experiments monitored by CD and 
fluorescence spectroscopies indicate that there are structural differences between TCEP-treated 
samples before and after dialysis. ICP-MS on the two dialysed TCEP- and TCEP/EDTA-treated 
samples show that there is no significant difference between all the treated samples compared to 




Mol metal ions 











Table 4. ICP-MS metal analysis of iron and zinc in TCEP- and TCEP/EDTA-treated oxygenase 
pre- and post-dialysis.  Samples were incubated at room temperature 16 h overnight before dialysis. 
Final concentrations of samples were 1.8 to 2.2 μM.  
 
Effects of Urea on the CD Spectra of Native Oxygenase 
 
  Since EDTA and thiol reagent treatment failed to remove metal ions from the oxygenase, 
additional reagents were tested for removal of Zn
2+
.  In this section, the effects of the protein 
denaturant, urea, on the structure of the protein were examined. Varying concentrations of urea 
(0.5 to 6 M) were incubated with wild-type oxygenase at room temperature for 16 h, before 




 A   
             
             B  
Figure 14. Circular dichroism spectra of native oxygenase incubated with varying concentrations of 
urea. Incubation of samples was at room temperature for 16h. A. Urea concentrations from 0 to 2 M. B. 
Urea concentrations from 2.5 to 6 M. Wavelength signals below 218 nm were cut off due to excessive 
noise. Samples (400 μL) with 0.45 μM protein at different urea concentrations were contained in a 0.2 cm 
path length cell. Each sample scan was the result of an average of five accumulations at room temperature 

























































Incubation of the oxygenase with 0 to 2 M urea showed an initial change in -helical 
structure from 0 to 0.5 M, with very little additional change from 0.5 to 2 M (Fig. 14A). 
Experiments with 2.5 to 6 M urea are shown in Fig. 14B, and the steady decrease in CD signal 
indicates unfolding. The nature of the structural change that occurs with 0.5 M urea is not known, 
but it appears to perturb the structure without unfolding it.  
Metal Content of Urea-Treated Oxygenase in the Presence of EDTA and DTT 
 Although results shown in the previous sections indicates that EDTA and DTT are 
ineffective in removal of metal ions from the oxygenase, the structural change caused by 
addition of urea (Fig. 14) may make it easier for reducing and chelating agents to gain access to 
the metal-binding site.  
Initially, a concentration of 5 M urea was used to test whether denaturation by urea would 
facilitate the chelation of the metal ions. Oxygenase was incubated with EDTA (5 mM), DTT (2 
mM) and urea (5 M) at room temperature for 6 h before dialysis at 4 
o
C. Initially, the metal-free 
dialysis buffer contained EDTA (5 mM) and DTT (2 mM), and subsequent buffer exchange was 
against only metal-free buffer. Dialysis buffers were changed three times over 3 days.  As is 
shown in Table 5, after treatment with urea (5 M) and EDTA/DTT, followed by dialysis, almost 
all of the iron and zinc in the oxygenase were depleted. This result is expected since the protein 






Samples Metal Species 
Mol metal ions 


















Table 5. ICP-MS metal analysis of EDTA/DTT and urea-treated oxygenase before and after 
dialysis. Oxygenase (60 μM) was incubated with EDTA (5 mM), DTT (2 mM) and urea (5 M) at room 
temperature for 6 h before dialysis or stored. The final concentration of protein was 2.2 μM. N/A 
represents not applicable data. 
 
Metal Analysis of EDTA- and EDTA/DTT-Treated Oxygenase after Column Buffer 
Exchange 
 
 In this section, buffer exchange using a desalting column was tested as an alternative to 
dialysis.   It is possible that prolonged dialysis risks introducing metal contaminants into apo-
enzyme preparations and that this could be avoided by a more rapid desalting procedure.  
Oxygenase was treated with EDTA or EDTA/DTT at room temperature for 16 h, as in the 
previous experiments. Metal ions and reagents were removed through metal-free buffer exchange 
in a NAP-5 column, which takes a period of a few minutes compared to days with dialysis.  
Table 6 shows the number of metal ions that remained bound to the protein after treatment with 










Mol metal ions 








* These values were the average of 2 values that 
differed by at most 30% 
 
Table 6. ICP-MS metal analysis of EDTA- and EDTA/DTT-treated oxygenase after NAP-5 column 
purification. EDTA (2 mM) and DTT (5 mM) were incubated with oxygenase (11 μM) at room 
temperature for 16 h before loading onto a mini-NAP-5 column. Final concentrations of samples were 0.2 
to 0.5 μM. 
 The Zn
2+
 content of both preparations was approximately two Zn
2+
 ions per mole of 
protein, indicating this method is ineffective in the removal of Zn
2+
. The iron content, however, 
was reduced to 2.9/mol protein without DTT addition and to 2.4/mol protein when DTT was 
added, as compared to 4.0/mol protein in the native enzyme (Table 1).  
Temperature Denaturation of Samples Prepared Using the NAP-5 Column 
 
 The far-UV CD spectra of EDTA and EDTA/DTT-treated oxygenase samples desalted 
using NAP-5 columns  (Figs. 15A & B) were similar to those observed for samples desalted 
using dialysis (Figs. 10A & B). After thermally denaturing the proteins by heating to 95 
o
C, the 
structures lost α-helicity but there was no obvious protein precipitate in the cuvette.  As the 
temperature denaturation curves in Fig. 15C show, complete unfolding of the treated oxygenase 
samples were not achieved (unlike the wild-type sample),  and the ellipticity at 222 nm for these 
samples remains around -15 mdeg. The Tm values for both EDTA-only and EDTA/DTT-treated 
oxygenase samples shifted to significantly lower temperature than the native enzyme (Fig. 15C), 





A      B   
 
C   
Figure 15. Far-UV CD spectra of EDTA-treated and EDTA/DTT-treated oxygenase after metal-
free buffer column exchange with NAP-5. A. EDTA-treated oxygenase scans at 25 
o
C and 95 
o
C. B. 
EDTA/DTT-treated oxygenase scans at 25 
o
C and 95 
o
C. C. Thermal denaturation curves of native 
oxygenase (control), EDTA-treated and EDTA/DTT-treated oxygenase. All final protein concentrations 
were 0.45 μM. 
 
 Temperature denaturation as followed by fluorescence spectroscopy for these treated 


































































emission wavelength maximum shift and fluorescence signal decrease as the treatment with 
dialysis for EDTA and EDTA/DTT (Fig. 11A & B). 
A  
B  
Figure 16. Intrinsic fluorescence monitored denaturation of EDTA and EDTA/DTT-treated-
oxygenase desalted using a NAP-5 metal-free buffer exchange column. A. Fluorescence intensity 
changes with increasing temperature. B. Emission maximum wavelength changes with increasing 
temperature. All wavelength values were obtained from the highest fluorescence intensity units at the 
specified temperature. Scans were collected at 5 
o
C intervals from 25 to 80 
o
C. The samples were from the 























































Metal Analysis of TPEN-Treated Oxygenase in the Presence of a Combination of DTT 
and/or Urea  
 
The possibility that a metal ion chelator other than EDTA might be more effective at 
removal of Zn
2+
 was also tested.  TPEN (N,N,N′,N′-Tetrakis(2-pyridylmethyl)ethylenediamine) 
is a chelator that is known to have a high affinity for Zn
2+
, and is permeable to cells
64
.  The 
oxygenase was incubated overnight with TPEN and DTT
65
, with or without urea (0.5 M), before 
buffer exchange by dialysis. Metal-free buffer without TPEN and DTT was used for dialysis, and 
changed three times over a period of three days. 
Prior to dialysis, all samples, both with and without urea, exhibited iron and zinc contents 
similar to the native oxygenase. After dialysis, however, both metal ion contents decreased as 
shown in Table 7.  These results also show that urea (0.5 M) aided the removal of Zn
2+
 under 
these conditions.  The structural changes induced by this low concentration of urea thus appear to 










Samples Metal Species 
Mol metal ions 

































            All values were from the average of two values that differed by at most 20% 
Table 7. ICP-MS metal analysis of TPEN and DTT-treated oxygenase in the presence or absence of 
urea, before and after dialysis. TPEN (5 mM), DTT (2 mM) and urea (0.5 M) were incubated with 
oxygenase (14.5 μM) at room temperature 16 h before dialysis or storage. The final concentration of 
samples was 0.5 μM.  
 
Temperature Denaturation of TPEN-Treated Oxygenase  
 
 The temperature denaturation of TPEN/DTT/urea-treated oxygenase was monitored by 
far-UV CD spectroscopy (Fig. 17): samples pre- (Fig. 17A) and post-dialysis (Fig. 17B) are 
shown.   At 95 
o
C, a limited CD signal is detected for either sample, and precipitate formed in the 
cuvette, indicating complete denaturation of the protein structure. Temperature denaturation 
curves in Fig. 17C show that ellipticity values at 222 nm at 25 
o
C for the native and treated 
proteins differ by 25 mdeg. This is consistent with Fig. 14A, where urea (0.5 M) induced a 
structural change that decreased the intensity of the CD signal in the 201 to 240 nm range, 
although apparently not to as great an extent.  
The Tm value of the pre-dialysis TPEN/DTT/urea-treated sample (red line, 58 
o
C) is 
lower than the Tm of the post-dialysis sample (green line, 62 
o
C), although this may simply be 
due to the presence of urea in the pre-dialysis sample.   Comparing these Tm values to that of the 
53 
 
native enzyme (blue line, 57 
o
C), treatment of the sample prior to dialysis is the same as the 
control and previous pre-dialysis samples (56 to 57 
o
C, Figs. 8B, 10C & 12C), but the dialysed 
TPEN/DTT/urea-treated sample gave a higher Tm value compared to other post-dialysis samples 
(range between 49 to 52 
o
C, Figs. 10C & 12C).  
A    B   
C   
Figure 17. Far-UV CD spectra of TPEN/DTT/urea-treated oxygenase before and after dialysis. A. 
Varianble temperature spectra (25 
o
C & 95 
o
C) of pre-dialysis oxygenase before dialysis. B. Treated post-
dialysis oxygenase spectra at 25 
o
C and 95 
o
C. C. Thermal denaturation curves of native oxygenase 


































































TPEN DTT urea before
dialysis
TPEN DTT urea dialysed
54 
 
 Temperature-induced denaturation was followed by fluorescence emission spectroscopy 
upon excitation at 280 nm (Fig. 18). The differences in starting fluorescence indicate structural 
differences between the samples that were dialyzed, compared to the undialyzed sample. At 80
o
C, 
the protein is unfolded as indicated by the very low fluorescence intensity signal and increase in 
wavelength.  Only very small differences in response to temperature were noted in the emission 
wavelength maximum for the two samples (data not shown).  
  
 
Figure 18. Intrinsic fluorescence to monitor denaturation of TPEN/DTT/urea-treated oxygenase, 
pre- and post-dialysis.  Scans were collected at every 5 
o
C time points from 25 to 80 
o
C at an excitation 
wavelength of 280 nm. The samples were from the same preparation for far-UV CD analysis. 
 




 Another column method that was used to remove reducing, chelating, and denaturing 
reagents and metal ions was through an in-house generated mini-Chelex
®
 column. The Chelex
®
 

































incubation with the appropriate reagents (refer to Table 8) was to buffer-exchange the samples 
with metal-free TG buffer in a NAP-5 column, then pass it through the mini-Chelex
®
 column.  
Samples Metal Species 
Mol metal ions 






























Table 8. ICP-MS metal analysis of DTT-treated oxygenase in the presence or absence of EDTA, 
TPEN and urea after Chelex® treatment. DTT (2 mM) and TPEN (5 mM) samples without urea with 
oxygenase (14.5 μM) were incubated at room temperature for 16 h before treatment. DTT (50 mM), 
EDTA (5 mM) and urea (5 M) were incubated with oxygenase (14.5 μM) at room temperature for 6 h 
before treatment. Final concentrations of samples were 0.5 to 2 μM.  
 
 The results presented in Table 8 indicate that the combination of reagents that is the most 
effective at removing the zinc ion is TPEN with DTT, consistent with the previous TPEN-treated 
experiment (Table 7), decreasing the amount of zinc metal to 0.1/mol oxygenase. However, this 










 Phenol hydroxylase of Pseudomonas sp. CF600 is a multicomponent enzyme comprised 
of different subunits, with oxygenase (DmpLNO) being the component where hydroxylation 
occurs. The enzyme also has been isolated from other bacterial species, where it has a similar 
role. At the oxygenase active site, diiron centre metal ions are bound and coordinated by 
glutamate and histidine residues
37
. The average number of iron atoms important for oxygenase 
activity
35 
in the oxygenase is approximately 4, and zinc is also always found in metal analysis 
experiments
35,Error! Bookmark not defined.
. 
 The objective of this project was to determine the role of Zn
2+
 found in the oxygenase 
component of phenol hydroxylase. First, expression of variant oxygenases modified at one of the 
four cysteine residues was attempted, and when that failed, methods for generating an apo-Zn
2+
 
enzyme were examined. No previous experimental studies have been reported on the Zn
2+
 
binding site of this or similar oxygenases. 
As was pointed out in the Introduction, two of the four cysteine residues that coordinate 
the metal ion binding site are found in the region of DmpN containing the YHS domain. This 
domain also includes a conserved tyrosine, histidine and serine-containing region that is found in 
all phenol hydroxylase enzymes that have a component similar to DmpK, previously shown to be 
important for the assembly of the active site into the oxygenase component, DmpLNO
54
. The 
location of the YHS domain, residues 409-452 in the oxygenase
66
, is important because it 
coincides with that of the Zn
2+ 
binding site. The YHS domain may be involved in the assembly 
of the oxygenase component, since genes encoding DmpK-related proteins are encoded together 





 Variant proteins with a cysteine to alanine substitution at the zinc-binding site were 
previously prepared by a M.Sc. student in the lab, Amy Wong
57
. There are four cysteine residues 
that coordinate the zinc-binding site (C399, C402, C432 and C436) in the α-subunit of 
Pseudomonas sp. OX1, as was shown in the structure determined by Sazinky et al
37
. These 
amino acids in Pseudomonas sp. CF600 correspond to C400, C403, C433 and C437, respectively, 
of DmpN.  Substitution of one or more of these cysteine residues, and characterization of the 
resulting variant enzyme, would provide information about the importance of Zn
2+
, for example, 
about whether it plays a structural or catalytic role in the oxygenase. 
 Attempts to express and purify the variant proteins were originally performed by Amy 
Wong
57
, using the same methods of expression and purification as for the wild-type oxygenase. 
Soluble protein expression was low, even at lower temperatures (18 
o
C), and the oxygenase 
subunits were mostly present in inclusion bodies. Attempts to purify the soluble enzyme 
suggested that the three subunits, DmpLNO, of all the variant oxygenase did not co-purify as in 
the native protein. This could be an indication that without the four cysteine coordination to keep 
Zn
2+
 in place, the protein’s quaternary structure was destabilized, possibly helping to explain its 
presence in inclusion bodies.  
 In this study, an attempt was made to increase expression of soluble C437A variant 
oxygenase.  A small modification in the procedure included increasing the period for protein 
expression to 48 h from 16 h. In addition, ZnCl2 was added after expression to attempt to 
solubilize the inclusion bodies. It was thought that this might help to drive the incorporation of 
Zn
2+
 into the Zn-binding site and facilitate proper protein folding. Samples induced with IPTG 
(Fig. 7) showed higher expression of DmpLNO compared to samples that were not induced. 
58 
 
Although the oxygenase subunit expression increased, the protein mainly remained as inclusion 
bodies when comparing the supernatant and cell pellet samples by SDS-PAGE analysis (Fig. 7). 
Furthermore, addition of Zn
2+
 did not solubilize any portion of what was in the pellet.  The lack 
of success in these experiments, and others in the lab, in obtaining adequate amounts of variant 
proteins of the oxygenase indicated that another approach for studying the Zn
2+
-binding site of 
phenol hydroxylase component was required. 
 Removal of Zn
2+
 from the cysteine-coordinated site might be achieved using a 
combination of denaturants, reducing agents and chelating agents. Various combinations of these 
reagents were attempted, along with dialysis or other methods of desalting.  The metal content 
was analysed by inductively-coupled plasma mass spectrometry (ICP-MS) to verify the success 
of metal removal.  
As a reference point for these experiments, oxygenase was first studied to follow 
secondary and tertiary structural changes with thermal denaturation using far-UV circular 
dichroism (far-UV CD) and fluorescence spectroscopies, respectively. The secondary structure 
of the oxygenase (DmpLNO) is mainly α-helical, as observed in the crystal structure of the 
orthologue from Pseudomonas sp. OX1 that has 78% sequence identity to oxygenase in 
Pseudomonas sp. CF600
Error! Bookmark not defined.
. In the far-UV CD spectra collected for DmpLNO 
at a temperature of 25 
o
C, there are two peak signals at 222 and 208 nm, which are characteristic 
of α-helices67. At 95 oC, there is loss of α-helical structure in the wild-type protein as indicated 
by the denaturation curve (Fig. 8B) and the loss of ellipticities at 222 and 208 nm (Fig. 8A). 
Visible insoluble protein was observed in the sample solution after this experiment was 
completed, consistent with irreversible denaturation of the protein.  
59 
 
Thermal denaturation of the oxygenase was also measured using fluorescence 
spectroscopy with an excitation wavelength of 280 nm, and monitoring the emission spectra of 
tryptophan and tyrosine residues. ICP-MS results of the native oxygenase preparations used 
showed an average of 4.0 ± 0.5 Fe
2+ 
/mole of protein and 2.5 ± 0.5 Zn
2+
/mole protein, which is 
similar to previous studies
35,Error! Bookmark not defined.
. 
As the temperature increased, a decrease in fluorescence intensity was observed, together 
with a red-shift to 347 nm from the initial wavelength maximum at 337 nm. Unfolding of the 
protein structure exposes the aromatic residues to the hydrophilic environment, hence lowering 
the quantum yield of the residues and shifting the spectrum to longer wavelengths. 
 Various reagents, including thiol reagents, chelators and denaturants, were tested for their 
ability to remove Zn
2+
 from the oxygenase. Tests were first performed by incubating the 
oxygenase with a reducing agent, dithiothreitol (DTT) that is small in size, a relatively good 
reductant and is capable of forming a complex with zinc
68
, followed by dialysis against metal-
free buffer.  A reducing agent would keep the cysteine sulfur groups in the thiol form, and that 
may help in removing Zn
2+
, or at least prevent the cysteine residues from oxidizing when Zn
2+
 is 
removed. As shown by the ICP-MS results (Table 2), the zinc content did not decrease after such 
a treatment. 





: it was added together with DTT to see if the two reagents together could remove the metals. 
The reducing agent can keep the protein thiol groups reduced, while EDTA could potentially 
sequester Zn
2+
 from the oxygenase. The ICP-MS results pre- and post-dialysis show that both 
zinc and iron contents are unchanged by this treatment (Table 3). 
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 In response to temperature, as monitored by far-UV CD and fluorescence spectroscopies, 
all pre-dialysis EDTA/DTT samples appeared to undergo loss of  structure in a manner similar to 
untreated oxygenase (Figs. 10A & 11, respectively). As seen from using CD spectroscopy, the 
post-dialysis samples after heating at 95 
o
C showed incomplete denaturation. The denaturation 
profile monitored at 222 nm shows Tm values of 52 and 50 
o
C for both EDTA and EDTA/DTT 
treated samples, respectively, and the signal plateaued well before it reached anywhere near zero 
mdeg. α-Helix to β-sheet transformations are common among many α-helical proteins whether it 
is due to chemical, pH or temperature change
69
. Although the oxygenase subunit of phenol 
hydroxylase fits the criteria of being mainly α-helical and has more than the minimum number of 
amino acids required for the α-β transition, it is difficult to determine if this transition is 
happening to the structure upon increasing temperature since ellipticity at 208 nm becomes 
obscured by the background noise. 
 Tris(2-carboxyethyl)phosphine (TCEP) is an effective reductant that contains no thiol 
groups, but is very effective in keeping disulfide bonds reduced in both acidic and basic 
conditions, unlike DTT which easily oxidizes around neutral pH
70
. Treatment by TCEP alone or 
in combination with EDTA was examined, and all post-dialysis samples also failed to denature 
completely after heating to 95 
o
C as shown in the CD spectra (Fig. 12), similar to the post-
dialysis preparations treated with EDTA and DTT. Complete unfolding and denaturation of the 
oxygenase protein occurred with samples only prior to buffer exchange using dialysis. 
From the two sets of experiments (EDTA/DTT and EDTA/TCEP treatments), post-
dialysis denaturation data indicated that dialysis of the samples is likely the cause of a structural 
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change in the protein that results in incomplete unfolding, unlike the native enzyme or pre-
dialysis samples which show complete unfolding.  
 As with the EDTA-treated and DTT-treated samples, ICP-MS results for the TCEP-
treated oxygenase showed that Zn
2+
 is not removed from the enzyme, and there is also very little 
loss of iron. Therefore, the structural changes that are implied by the inability to completely 
denature the enzyme after these treatments do not appear related to metal ion removal. 
 The possibility that a protein denaturant such as urea could help to remove metal ions 
from the oxygenase was examined.  Addition of urea (5 M) to EDTA/DTT treated oxygenase 
followed by dialysis gave an ICP-MS result that showed lowered zinc content in the pre- to post-
dialysis samples, from 1.9 to 0.1 Zn
2+
 per mol protein, and iron content was also affected with 
values decreasing from 4.0 to 0.1 Fe
2+
 per mol protein when compared to the untreated protein. 
The concentration of 5 M is high, so it is expected that the protein would unfold completely, 
consistent with the observation that the CD signal decreases from -25 mdeg in the native enzyme 
to -9 mdeg at 5 M urea at 222 nm (Fig. 14). Loss of metal ions would be expected for completely 
unfolded protein, and would be removed by buffer exchange. However, if possible, it would be 
preferable not to completely unfold the enzyme but instead perturb the structure enough to 
facilitate metal ion removal.  Thus, a test was performed using oxygenase incubated with varying 
concentrations of urea (0 to 8 M, Figs. 14A & B) to determine the minimum amount of urea that 
might perturb the structure of the oxygenase without significant unfolding. As is shown in Fig. 
14A, 0.5 M urea appeared to be a suitable concentration that did not alter the α-helical structure 
much. Inclusion of 0.5 M urea was further tested in experiments to remove metal ions. 
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Tetrakis-(2-Pyridylmethyl)ethylenediamine (TPEN) is a chelator that has been used for 
intracellular chelation of zinc
63
. It was used, together with DTT in the presence and absence of 
urea, followed by dialysis, to attempt Zn
2+
 removal from the oxygenase. ICP-MS results showed 




 in the presence of urea/DTT/TPEN with the metal content 
decreasing from 4.0 mol Fe
2+
 and 2.5 mol Zn
2+ 
to 0.3 and 0.1 mol iron and zinc, respectively, per 
mol of oxygenase (Table 7). In the absence of urea, the Zn
2+
 content of 1.3 mol/mol oxygenase 
was significantly higher than when urea was present, and Fe
2+
 was at 0.1 mol/mol oxygenase. 
Thus, urea is required in combination with the chelator and reducing agent, followed by dialysis, 
for the most effective removal of Zn
2+
. 
In the pre- and post-dialysis CD spectra of TPEN/DTT/urea treated oxygenase (Fig. 17A 
& B), the structure of the protein changes as indicated by the apparent loss of signal at 208 nm at 
25 
o
C and the protein completely denatures/precipitates out of the solution at 95 
o
C. Thermal 
denaturation of these samples indicates that the protein is unfolded by 95 
o
C (Fig. 17C).   What is 
interesting to note here is the Tm value (transition midpoint temperature) of the post-dialysis 
preparation at 62 
o
C, which is somewhat higher than that of the native enzyme (57 
o
C). Also, it 
has a Tm that is 12 to 13 
o
C higher compared to all previous post-dialysis samples (EDTA, 
EDTA/DTT, TCEP and TCEP/EDTA treatment), which may indicate an increase in stability of 
the protein. Fluorescence data (not shown) has indicated that the starting wavelength maxima at 
25 
o
C are at 341 and 343 nm for pre- and post-dialysis samples, respectively, compared to 336 or 
338 nm for untreated samples, indicating the protein structure is already partially unfolded after 
TPEN/DTT/urea treatment, exposing the aromatic residues to the hydrophilic environment. 
However, the fluorescence intensities of both samples are quite different, as the spectrum of 
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post-dialysis sample starts at intensity twice as high compared to that of pre-dialysis sample (Fig. 
18).   
 Although dialysis is a method that is effective at reagent removal, it is a lengthy process 
and requires treatment of large buffer volumes with an expensive metal chelating resin.  Column-
based buffer exchange was thus tested as an alternative to dialysis. The first set of experiments 
used a NAP-5 column (GE Healthcare) to remove reagents after the oxygenase was treated with 
the chelator, EDTA, in the presence or absence of DTT (see Materials and Methods). Results of 
thermal denaturation as monitored by Far-UV CD and fluorescence spectroscopies mirrored 
those of the equivalent experiment performed using dialysis to remove EDTA and DTT. Metal 
analysis of samples after the NAP-5 column step confirmed that Zn
2+
 was not successfully 
removed, but there was significant loss of iron (Table 6). 
 Another column-based procedure was a mini-Chelex
®
 column, whose resin can bind 
metal ions. Thus, oxygenase samples that had been treated with DTT, TPEN/DTT, DTT/urea or 
EDTA/DTT/urea were passed through a Chelex
®
 column, and then tested for metal content 
(Table 8). ICP-MS showed that the most efficient combination was TPEN/DTT treatment, 
followed by Chelex chromatography, resulting in 0.1 mol of zinc and iron per mol of oxygenase. 
The other three samples had roughly the same zinc content, averaging 1.2 mol/mol oxygenase, so 
TPEN and DTT are most effective at removing Zn
2+







 The inability to successfully express variants of DmpLNO oxygenase where any of the 
Zn
2+
-binding ligands had been substituted suggests that this metal ion plays a role in stabilizing 
the protein structure.   The results presented in this thesis indicated that a combination of the 
Zn
2+
 chelator, TPEN, the reductant, DTT, and a low concentration the protein denaturant, urea, 
followed either by dialysis or a Chelex column, effectively removed both zinc and iron.  The 
spectroscopic experiments indicated that these samples had altered CD and fluorescence spectra, 
but the thermal denaturation experiments indicated that the apo-protein stability was similar to 














 Although removal of Zn
2+
 from the oxygenase was accomplished, Fe
2+
 was also removed 
from the enzyme.  In order to study the role of Zn
2+
, it is necessary to have a preparation that has 
an intact binuclear iron centre.  Accordingly, future studies should include the addition of Fe
2+
 to 
the apo-enzyme, using procedures that have already been developed
35
. The activity of the 
enzyme before and after the addition of Zn
2+
 would be monitored. Secondary and tertiary 
structure in the presence and absence of Zn
2+ 
would be examined using circular dichroism and 
fluorescence spectroscopies, and protein stability would be probed by thermal or chemical 
denaturation studies. 
 The importance of individual residues in the Zn
2+
 binding site could be best probed by 
characterizing variants of the oxygenase.  However, work with variant proteins that were 
generated in the present study proved it was difficult since the proteins were found exclusively in 
the particulate fraction with the formation of inclusion bodies. There are published protocol 
methods available to purify proteins expressed in inclusion bodies. These include solubilization 
of the inclusion bodies by using denaturants (GdHCl or urea) or detergents (SDS)
71
 and then 
refolding the protein in the presence and absence of Zn
2+
 to recover the variant enzyme. 
Refolding the enzyme under study may be difficult, however, because of the many subunits it 
possesses. If this approach were successful, the variant proteins can be tested for enzyme activity, 
structural changes and stability to probe the roles of variants with alterations of amino acids at 
the Zn
2+
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